Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 24,050.0 | $12.6M | 1.55% | +4K | +23.0% | $523.47 | -0.2% |
| 22 | UNH | UNITED HEALTH GROUP INC | Healthcare | 45,500.0 | $12.3M | 1.52% | -9K | -17.1% | $270.59 | +45.0% |
| 23 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 475,000.0 | $11.9M | 1.47% | -136K | -22.3% | $25.01 | +4.4% |
| 24 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 207,000.0 | $11.7M | 1.44% | -8K | -3.7% | $56.49 | -11.2% |
| 25 | ABT | ABBOTT LABORATORIES | Healthcare | 112,000.0 | $11.5M | 1.42% | NEW | — | $102.67 | -13.7% |
| 26 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 34,465.0 | $11.4M | 1.41% | -11K | -24.5% | $330.87 | -11.7% |
| 27 | RPRX | ROYALTY PHARMA PLC | Healthcare | 233,000.0 | $11.2M | 1.38% | +26K | +12.8% | $47.97 | +9.1% |
| 28 | AXSM | AXSOME THERAPEUTICS INC | Healthcare | 63,800.0 | $10.8M | 1.33% | -51K | -44.4% | $169.02 | +34.4% |
| 29 | NTRA | NATERA INC | Healthcare | 51,600.0 | $10.3M | 1.27% | +11K | +27.4% | $199.99 | -2.8% |
| 30 | THC | TENET HEALTHCARE CORP | Healthcare | 54,000.0 | $10.2M | 1.26% | -23K | -29.4% | $188.71 | +1.2% |
| 31 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 720,000.0 | $10.0M | 1.23% | +115K | +19.0% | $13.88 | -7.9% |
| 32 | LIVN | LIVANOVA PLC | Healthcare | 155,000.0 | $9.9M | 1.22% | -35K | -18.4% | $63.56 | +15.8% |
| 33 | ELV | ELEVANCE HEALTH INC | Healthcare | 32,300.0 | $9.5M | 1.17% | +17K | +115.3% | $292.75 | +38.0% |
| 34 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 144,500.0 | $9.1M | 1.12% | — | — | $62.70 | +16.7% |
| 35 | GKOS | GLAUKOS CORP | Healthcare | 84,000.0 | $9.0M | 1.12% | -126K | -60.0% | $107.66 | +31.9% |
| 36 | — | IQVIA HLDGS INC | — | 53,000.0 | $9.0M | 1.11% | +26K | +100.0% | $170.54 | — |
| 37 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 379,250.0 | $8.9M | 1.09% | -108K | -22.1% | $23.36 | -17.3% |
| 38 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 92,605.0 | $8.6M | 1.06% | -14K | -12.8% | $92.38 | +4.7% |
| 39 | IDYA | IDEAYA Biosciences Inc | Healthcare | 255,500.0 | $8.5M | 1.05% | +6K | +2.2% | $33.32 | -14.5% |
| 40 | PNTG | PENNANT GROUP INC | Healthcare | 275,399.0 | $8.4M | 1.04% | -82K | -22.9% | $30.48 | +16.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%